ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 224 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $326 | -41.5% | 7,060 | -49.2% | 0.04% | -19.6% |
| Q1 2023 | $557 | -99.9% | 13,890 | -33.7% | 0.05% | -40.7% |
| Q3 2022 | $868,000 | -10.9% | 20,950 | +105.0% | 0.09% | -12.2% |
| Q2 2021 | $974,000 | +286.5% | 10,220 | +462.5% | 0.10% | +139.0% |
| Q4 2020 | $252,000 | -59.2% | 1,817 | -79.6% | 0.04% | -59.4% |
| Q1 2019 | $617,000 | +174.2% | 8,900 | +93.2% | 0.10% | +65.6% |
| Q2 2016 | $225,000 | – | 4,606 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |